IL299451B2 - מיצוי אלקלואיד פסיכואקטיבי מפוספס בעיקר באמצעות אלקלי - Google Patents
מיצוי אלקלואיד פסיכואקטיבי מפוספס בעיקר באמצעות אלקליInfo
- Publication number
- IL299451B2 IL299451B2 IL299451A IL29945122A IL299451B2 IL 299451 B2 IL299451 B2 IL 299451B2 IL 299451 A IL299451 A IL 299451A IL 29945122 A IL29945122 A IL 29945122A IL 299451 B2 IL299451 B2 IL 299451B2
- Authority
- IL
- Israel
- Prior art keywords
- psychoactive
- alkaloid
- solvent
- weight
- psychoactive alkaloid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/078—Psilocybe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0215—Solid material in other stationary receptacles
- B01D11/0253—Fluidised bed of solid materials
- B01D11/0257—Fluidised bed of solid materials using mixing mechanisms, e.g. stirrers, jets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/028—Flow sheets
- B01D11/0284—Multistage extraction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0292—Treatment of the solvent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040317P | 2020-06-17 | 2020-06-17 | |
| US202063046089P | 2020-06-30 | 2020-06-30 | |
| CA3088384A CA3088384C (en) | 2020-06-17 | 2020-07-29 | Extraction of psychoactive compounds from psilocybin fungus |
| CA3089455A CA3089455C (en) | 2020-06-17 | 2020-08-07 | Methanol-based extraction of psychoactive compounds from fungus |
| CA3097246A CA3097246C (en) | 2020-10-23 | 2020-10-23 | Process for obtaining a purified psychoactive alkaloid solution |
| CA3101765A CA3101765A1 (en) | 2020-12-04 | 2020-12-04 | Psychoactive alkaloid extraction and composition with controlled dephosphorylation |
| CA3103707A CA3103707C (en) | 2020-12-18 | 2020-12-18 | Standardized psychoactive alkaloid extract composition |
| PCT/CA2021/050813 WO2021253116A1 (en) | 2020-06-17 | 2021-06-14 | Compositions comprising psychoactive compounds from psychoactive organisms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL299451A IL299451A (he) | 2023-02-01 |
| IL299451B1 IL299451B1 (he) | 2024-08-01 |
| IL299451B2 true IL299451B2 (he) | 2024-12-01 |
Family
ID=79022851
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL305632A IL305632B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליות |
| IL299452A IL299452B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי והרכב אלקלואידים פסיכואקטיביים עם דה–פוספורילציה מבוקרת |
| IL299448A IL299448B2 (he) | 2020-06-17 | 2021-06-14 | תהליך להשגת תמיסת אלקלואיד פסיכואקטיבית מטוהרת |
| IL299453A IL299453B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי והרכב אלקלואידים פסיכואקטיביים עם דה–פוספורילציה מעוכבת |
| IL299450A IL299450A (he) | 2020-06-17 | 2021-06-14 | מיצוי מבוקרת דה-פוספורילציה של אלקלואידים פסיכואקטיביים הניתנים לזרחני |
| IL299451A IL299451B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי אלקלואיד פסיכואקטיבי מפוספס בעיקר באמצעות אלקלי |
| IL299449A IL299449B2 (he) | 2020-06-17 | 2021-06-14 | הרכב תמצית אלקלואיד פסיכואקטיבי סטנדרטי |
| IL297791A IL297791B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליות |
| IL298561A IL298561B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי על בסיס מתנול של תרכובות פסיכואקטיביות מפטריה |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL305632A IL305632B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליות |
| IL299452A IL299452B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי והרכב אלקלואידים פסיכואקטיביים עם דה–פוספורילציה מבוקרת |
| IL299448A IL299448B2 (he) | 2020-06-17 | 2021-06-14 | תהליך להשגת תמיסת אלקלואיד פסיכואקטיבית מטוהרת |
| IL299453A IL299453B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי והרכב אלקלואידים פסיכואקטיביים עם דה–פוספורילציה מעוכבת |
| IL299450A IL299450A (he) | 2020-06-17 | 2021-06-14 | מיצוי מבוקרת דה-פוספורילציה של אלקלואידים פסיכואקטיביים הניתנים לזרחני |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299449A IL299449B2 (he) | 2020-06-17 | 2021-06-14 | הרכב תמצית אלקלואיד פסיכואקטיבי סטנדרטי |
| IL297791A IL297791B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליות |
| IL298561A IL298561B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי על בסיס מתנול של תרכובות פסיכואקטיביות מפטריה |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US11331357B2 (he) |
| EP (1) | EP4161546A4 (he) |
| AU (7) | AU2021290454B2 (he) |
| BR (1) | BR112022025780A2 (he) |
| IL (9) | IL305632B2 (he) |
| MX (1) | MX2022016533A (he) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114787363A (zh) | 2019-10-01 | 2022-07-22 | 恩派瑞安神经科学公司 | 对真菌进行遗传工程化以调节色胺表达 |
| CA3197443C (en) | 2020-12-28 | 2024-10-22 | Psilo Scientific Ltd. | METHODS FOR EXTRACTION OF PSYCHOACTIVE ALKALOIDS AND RELATED PREPARATION IN TRANSMUCOSAL FORMS |
| US20220370413A1 (en) | 2021-03-06 | 2022-11-24 | Mind Medicine, Inc. | Formulations of psilocin that have enhanced stability |
| CA3127180C (en) * | 2021-08-06 | 2024-03-05 | Psilo Scientific Ltd. | Pre-evaporation standardization of extracted psychoactive compounds |
| CA3232692A1 (en) * | 2021-09-28 | 2023-04-06 | Joseph Girardi | Chilled juice extraction processes and products using psychedelic and functional mushrooms |
| CA3133547C (en) * | 2021-10-07 | 2024-07-02 | Psilo Scientific Ltd. | LIQUID-LIQUID EXTRACTION OF PURIFIED PSYCHOACTIVE ALKALOIDS |
| WO2023130078A2 (en) | 2021-12-31 | 2023-07-06 | Empyrean Neuroscience, Inc. | Genetically modified mycelium for producing psychotropic alkaloids |
| WO2023225186A1 (en) * | 2022-05-18 | 2023-11-23 | Chemtor, Lp | Extraction of psilocybin and psilocin |
| GB202313750D0 (en) | 2023-09-08 | 2023-10-25 | Psyence Group Inc | A process for obtaining a purified psychoactive alkaloid |
| AU2024367931A1 (en) | 2023-10-23 | 2026-02-26 | Reconnect Labs Ag | Pharmaceutical formulations comprising 5-meo-dmt and their therapeutic uses |
| US12611417B1 (en) * | 2025-06-03 | 2026-04-28 | Convergent Health Sciences LLC: | Compositions and methods to inhibit acid-catalyzed dephosphorylation of phosphoryloxytryptamines |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE264023C (he) | ||||
| LU36879A1 (he) | 1958-02-21 | |||
| GB911946A (en) * | 1958-02-21 | 1962-12-05 | Sandoz Ltd | Psilocybin and psilocin and processes for their preparation |
| DD264023A1 (de) * | 1987-07-17 | 1989-01-18 | Akad Wissenschaften Ddr | Verfahren zur extraktion von indolalkaloiden aus pilzmaterial |
| US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
| JP2005522460A (ja) | 2002-02-28 | 2005-07-28 | マリンクロッド・インコーポレイテッド | 逆相分取用クロマトグラフィーを用いる少なくとも１種の麻薬性アルカロイドの分離および精製のための方法およびシステム |
| SE0302947D0 (sv) | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
| AU2007295179B2 (en) | 2006-09-15 | 2013-05-30 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| CN101292727A (zh) * | 2008-05-30 | 2008-10-29 | 曹晋忠 | 菌类乙醇提取物的粉体制备方法 |
| JP5806287B2 (ja) | 2010-03-30 | 2015-11-10 | フォスファジェニクス リミティド | 経皮送達パッチ |
| ES2898173T3 (es) | 2014-06-30 | 2022-03-04 | Syqe Medical Ltd | Dispositivos y sistemas para la administración pulmonar de principios activos |
| US20180021326A1 (en) | 2016-07-23 | 2018-01-25 | Paul Edward Stamets | Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin |
| NL2018190B1 (en) | 2017-01-18 | 2018-07-26 | Procare Beheer B V | Psilocybin or psilocin in combination with cannabinoid |
| CA3052974A1 (en) | 2017-02-09 | 2018-08-16 | CaaMTech, LLC | Compositions and methods comprising a psilocybin derivative |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| WO2019099745A1 (en) * | 2017-11-16 | 2019-05-23 | CaaMTech, LLC | Compositions comprising a psilocybin derivative and a cannabinoid |
| CN109528846A (zh) * | 2018-12-27 | 2019-03-29 | 贵州理工学院 | 一种植物中生物碱提取纯化的方法 |
| EP4230195A1 (en) | 2019-03-07 | 2023-08-23 | Arbormentis LLC | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations |
| US20220194992A1 (en) | 2019-04-26 | 2022-06-23 | The University Of North Carolina At Chapel Hill | Methods and compositions for dual glycan binding aav2.5 vector |
| CA3097246C (en) | 2020-10-23 | 2023-03-28 | Psilo Scientific Ltd. | Process for obtaining a purified psychoactive alkaloid solution |
| US20220304980A1 (en) | 2019-07-04 | 2022-09-29 | SW Holdings, Inc | Metered dosing compositions and methods of use of psychedelic compounds |
| US11208117B2 (en) | 2019-07-09 | 2021-12-28 | Refraction Ai, Inc. | Method and system for autonomous vehicle control |
| WO2021159213A1 (en) * | 2020-02-12 | 2021-08-19 | Neonmind Biosciences Inc. | Method for producing an extract of mushroom and mushroom extract made therefrom |
| US11382942B2 (en) | 2020-06-17 | 2022-07-12 | Psilo Scientific Ltd. | Extraction of psychoactive compounds from psilocybin fungus |
| CA3124367C (en) | 2020-06-17 | 2022-04-26 | Psilo Scientific Ltd. | Aqueous extraction of psychoactive compounds from psilocybin fungus |
| US20220054402A1 (en) | 2020-11-05 | 2022-02-24 | Richard C Kaufman | Compositions and methods for extracting, stabilizing, and manufacturing stable dosage forms of psilocin, psychedelic drugs, entheogens, and medicinal mushrooms as nano-dimensional drug delivery structures |
| US20220331292A1 (en) | 2021-04-16 | 2022-10-20 | Callitas Health Inc. | Compositions and methods for delivery of psilocin and prodrugs thereof |
| US12440472B2 (en) | 2021-06-16 | 2025-10-14 | Intelgenx Corp. | Stable tryptamine oral films |
-
2021
- 2021-06-14 MX MX2022016533A patent/MX2022016533A/es unknown
- 2021-06-14 EP EP21825817.6A patent/EP4161546A4/en active Pending
- 2021-06-14 AU AU2021290454A patent/AU2021290454B2/en active Active
- 2021-06-14 IL IL305632A patent/IL305632B2/he unknown
- 2021-06-14 IL IL299452A patent/IL299452B2/he unknown
- 2021-06-14 IL IL299448A patent/IL299448B2/he unknown
- 2021-06-14 IL IL299453A patent/IL299453B2/he unknown
- 2021-06-14 IL IL299450A patent/IL299450A/he unknown
- 2021-06-14 IL IL299451A patent/IL299451B2/he unknown
- 2021-06-14 BR BR112022025780A patent/BR112022025780A2/pt unknown
- 2021-06-14 IL IL299449A patent/IL299449B2/he unknown
- 2021-06-14 IL IL297791A patent/IL297791B2/he unknown
- 2021-06-14 IL IL298561A patent/IL298561B2/he unknown
- 2021-06-15 US US17/348,697 patent/US11331357B2/en active Active
- 2021-09-23 US US17/483,601 patent/US11298388B2/en active Active
-
2022
- 2022-03-17 US US17/697,798 patent/US11571450B2/en active Active
- 2022-03-23 US US17/702,701 patent/US11642385B2/en active Active
- 2022-12-19 AU AU2022291411A patent/AU2022291411B2/en active Active
- 2022-12-19 AU AU2022291416A patent/AU2022291416B2/en active Active
- 2022-12-19 AU AU2022291410A patent/AU2022291410B2/en active Active
- 2022-12-19 AU AU2022291414A patent/AU2022291414B2/en active Active
- 2022-12-19 AU AU2022291413A patent/AU2022291413B2/en active Active
-
2023
- 2023-12-19 AU AU2023285751A patent/AU2023285751B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023285751B2 (en) | Powdered Composition Containing a Mushroom Extract Comprising a Psychoactive Alkaloid | |
| CA3173030C (en) | Predominantly phosphorylated psychoactive alkaloid extraction using alkali | |
| US11382942B2 (en) | Extraction of psychoactive compounds from psilocybin fungus | |
| US11510952B2 (en) | Ethanol extraction of psychoactive compounds from psilocybin fungus | |
| CA3137016C (en) | Psychoactive alkaloid extraction and composition with inhibited dephosphorylation |